Close

Agios Pharma (AGIO) Submits sNDA to FDA for TIBSOVO for Patients with Previously Treated IDH1-Mutant Cholangiocarcinom

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/24/2024

1. TSLA
2. SPY
3. SPOT
4. GM
5. AMZN
6. SHW
7. MSCI
8. AAPL
9. NVDA


Go back to Agios Pharma (AGIO) Submits sNDA to FDA for TIBSOVO for Patients with Previously Treated IDH1-Mutant Cholangiocarcinom
AGIOS PHARM (NASDAQ: AGIO) Delayed: 31.81 --0 (-0%)
Previous Close $31.81    52 Week High $71.49 
Open $31.81    52 Week Low $33.50 
Day High $31.81    P/E N/A 
Day Low $31.81    EPS $-1.18 
Volume 24